Primary Hyperoxaluria Treatments
Find Primary Hyperoxaluria Treatments
Brand Name
Rivfloza
Generic Name
Nedosiran
View Brand Information FDA approval date: February 19, 2024
Form: Injection
What is Rivfloza (Nedosiran)?
RIVFLOZA is indicated to lower urinary oxalate levels in children 2 years of age and older and adults with primary hyperoxaluria type 1 and relatively preserved kidney function, e.g., eGFR ≥30 mL/min.
Approved To Treat
Save this treatment for later
Not sure about your diagnosis?
Tired of the same old research?
Related Clinical Trials
There is no clinical trials being done for this treatment